In human prostate cancer cells, vimentin is phosphorylated at Ser33, Ser39 and Ser56 by atypical PKCs at the cell front, leading to the local disassembly of vimentin IFs, lamellipodium formation and cell migration (Ratnayake et al., 2021). This evidence concerns the gene VIM and prostate carcinoma.